• Featured Product
  • KD/KO Validated

LIMD2 Polyclonal antibody

LIMD2 Polyclonal Antibody for WB, IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IF, IHC, ELISA

Conjugate

Unconjugated

Cat no : 15471-1-AP

Synonyms

LIM domain containing 2, LIMD2


☆対象製品が30%オフ!組換えタンパク質&免染用試薬 >>> キャンペーン実施中!


Tested Applications

Positive WB detected inU-937 cells, Raji cells
Positive IHC detected inhuman liver cancer tissue, human brain tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:200-1:1000
Immunohistochemistry (IHC)IHC : 1:20-1:200
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

15471-1-AP targets LIMD2 in WB, IF, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen LIMD2 fusion protein Ag7775 相同性解析による交差性が予測される生物種
Full Name LIM domain containing 2
Calculated molecular weight 14 kDa
Observed molecular weight 16-20 kDa
GenBank accession numberBC004400
Gene symbol LIMD2
Gene ID (NCBI) 80774
RRIDAB_10859817
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Protocols

Product Specific Protocols
WB protocol for LIMD2 antibody 15471-1-APDownload protocol
IHC protocol for LIMD2 antibody 15471-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanIF

Bioengineered

LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway.

Authors - Lixin Chen
humanWB

Mol Biol Rep

Knockdown of LIMD2 inhibits the progression of ovarian carcinoma through ERK1/2 pathway

Authors - Haiyang Hu
  • KD Validated